| P50 | author | Enrique Roche | Q57337490 |
| P2093 | author name string | Bernat Soria | |
| | Roy Y Calne | |
| | John R Isaac | |
| | Adolfo Campos | |
| | Susan Lim | |
| | Beatriz Paredes | |
| | Juan Antonio Reig | |
| P2860 | cites work | Insulin signalling and the regulation of glucose and lipid metabolism | Q24292020 |
| | Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains | Q24297459 |
| | Nuclear reprogramming and stem cell creation | Q24620354 |
| | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
| | New perspectives into the molecular pathogenesis and treatment of type 2 diabetes | Q28203726 |
| | Regulation of insulin gene transcription | Q28210255 |
| | Genetics of type 1 diabetes mellitus | Q28215982 |
| | Obesity wars: molecular progress confronts an expanding epidemic | Q28240764 |
| | Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 |
| | Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion | Q28368982 |
| | Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group | Q28374428 |
| | Transcription factors direct the development and function of pancreatic beta cells | Q28609099 |
| | Global and societal implications of the diabetes epidemic | Q29614551 |
| | Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation | Q29614736 |
| | The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation | Q29617813 |
| | Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 | Q29619280 |
| | Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier. | Q33213652 |
| | Five-year follow-up after clinical islet transplantation | Q33218078 |
| | Tacrolimus: the drug for the turn of the millennium? | Q33635664 |
| | Spontaneous human adult stem cell transformation. | Q53358878 |
| | In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. | Q53888618 |
| | Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. | Q55034045 |
| | Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 |
| | The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry | Q55670898 |
| | Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells | Q56903879 |
| | Fate of teratocarcinoma cells injected into early mouse embryos | Q59085799 |
| | Sirolimus-tacrolimus combination immunosuppression | Q60998185 |
| | Inhibition of the immune response by rapamycin, a new antifungal antibiotic | Q67555498 |
| | FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro | Q69010285 |
| | Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment | Q70311233 |
| | The effects of feeding and various hormones on the glucose tolerance of the sand rat (psammomys obesus) | Q72003023 |
| | High-level expression of interleukin-4 following electroporation-mediated gene transfer accelerates Type 1 diabetes in NOD mice | Q73174050 |
| | Interleukin 12 and autoimmune diabetes | Q73435269 |
| | Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21 | Q73800704 |
| | Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells | Q74573056 |
| | Peritoneal antigen-presenting cells pulsed in vivo with myelin basic protein induce the suppression of experimental autoimmune encephalomyelitis (EAE) in Wistar rats | Q77397628 |
| | Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice | Q77488356 |
| | Microchimerism and the pathogenesis of systemic sclerosis | Q77542609 |
| | Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells | Q77744347 |
| | Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice | Q78719270 |
| | Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice | Q78946090 |
| | Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles | Q33670571 |
| | Isolation, characterization, and chromosomal localization of the human ENSA gene that encodes alpha-endosulfine, a regulator of beta-cell K(ATP) channels | Q33873543 |
| | Autonomic regulation of islet hormone secretion--implications for health and disease | Q33923510 |
| | Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms | Q33942274 |
| | Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. | Q33944464 |
| | In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells | Q34031221 |
| | Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting | Q34102284 |
| | Considerations for successful transplantation of encapsulated pancreatic islets | Q34122328 |
| | Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach | Q34163786 |
| | Mammalian cloning: advances and limitations. | Q34185440 |
| | From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. | Q34253731 |
| | Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells | Q34328388 |
| | Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice | Q34345367 |
| | Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts | Q34387398 |
| | Macrolactam immunomodulators for topical treatment of inflammatory skin diseases | Q34405192 |
| | Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells | Q34415516 |
| | RETRACTED: Patient-specific embryonic stem cells derived from human SCNT blastocysts. | Q34420078 |
| | Embryo-derived stem cells: of mice and men. | Q34425188 |
| | Diabetes mellitus and genetically programmed defects in beta-cell function | Q34462316 |
| | beta-Cell death during progression to diabetes | Q34462324 |
| | Beta-cell protein kinases and the dynamics of the insulin response to glucose | Q34508739 |
| | Nonhuman primate parthenogenetic stem cells | Q34582548 |
| | Is IL12B a potential genetic target for the prevention of type 1 diabetes through dietary intervention? | Q34700825 |
| | Immunologic and genetic factors in type 1 diabetes | Q34882557 |
| | Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits | Q34945872 |
| | Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes | Q35022159 |
| | Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? | Q35034481 |
| | Lipoapoptosis: its mechanism and its diseases | Q35047180 |
| | The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure | Q35103993 |
| | A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes | Q35170270 |
| | In vitro cultivation of human islets from expanded ductal tissue | Q35174217 |
| | Nuclear transplantation, embryonic stem cells, and the potential for cell therapy | Q35179632 |
| | Bio-engineering inslulin-secreting cells from embryonic stem cells: a review of progress | Q35189283 |
| | Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection | Q35208665 |
| | Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes | Q35641719 |
| | Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism | Q35641736 |
| | Chronic effects of fatty acids on pancreatic beta-cell function: new insights from functional genomics. | Q35641748 |
| | Plasticity of adult stem cells | Q35684656 |
| | Death effectors of beta-cell apoptosis in type 1 diabetes | Q35908961 |
| | Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal | Q35920996 |
| | Animal models have little to teach us about type 1 diabetes: 2. In opposition to this proposal | Q35926919 |
| | An immune origin of type 2 diabetes? | Q36112058 |
| | Models of T cell anergy: is there a common molecular mechanism? | Q36366967 |
| | Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. | Q37599148 |
| | Nuclei of embryonic stem cells reprogram somatic cells | Q38334452 |
| | Upstream AUGs in embryonic proinsulin mRNA control its low translation level. | Q38349516 |
| | Organized development from human embryonic stem cells after injection into immunodeficient mice. | Q40519575 |
| | Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells | Q40521874 |
| | Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells | Q40544422 |
| | Association between macrophage activation and function of micro-encapsulated rat islets | Q40587998 |
| | Insulin expressing cells from differentiated embryonic stem cells are not beta cells | Q40589116 |
| | Supplementation-dependent differences in the rates of embryonic stem cell self-renewal, differentiation, and apoptosis | Q40623756 |
| | Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines | Q40682221 |
| | Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. | Q40682801 |
| | Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy | Q40738121 |
| | Target cell defense prevents the development of diabetes after viral infection. | Q40741831 |
| | Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety | Q40761236 |
| | Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. | Q40876310 |
| | Genetic analysis of autoimmune disease | Q40980040 |
| | Upstream-downstream: CD28 cosignaling pathways and T cell function | Q41010604 |
| | Mechanisms of action of nonglucose insulin secretagogues | Q41053123 |
| | Cell death mediators in autoimmune diabetes--no shortage of suspects | Q41420580 |
| | Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition. | Q41513494 |
| | Six-year clinical effect of donor bone marrow infusions in renal transplant patients | Q43605131 |
| | Th2 dominance of T helper cell response to preproinsulin in individuals with preclinical type 1 diabetes. | Q44000561 |
| | Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. | Q44172552 |
| | Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background | Q44223925 |
| | Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells | Q44418714 |
| | A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo | Q44447045 |
| | IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction | Q44468596 |
| | Bone marrow-derived stem cells initiate pancreatic regeneration. | Q44486484 |
| | Differentiation of human embryonic stem cells into insulin-producing clusters | Q44903372 |
| | Lowered glucose suppressed the proliferation and increased the differentiation of murine neural stem cells in vitro | Q44997441 |
| | In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells | Q45199702 |
| | Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice | Q45868872 |
| | TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype | Q46431455 |
| | Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells | Q46531971 |
| | Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 |
| P433 | issue | 2 | |
| P304 | page(s) | 113-129 | |
| P577 | publication date | 2005-10-17 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes | |
| P478 | volume | 15 | |